Terms: = Prostate cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Diagnosis
24 results:
1. Smoking, Drinking, and Dietary Risk Factors for Head and Neck cancer in prostate, Lung, Colorectal, and Ovarian cancer Screening Trial Participants.
Lander DP; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):249-256. PubMed ID: 38329760
[TBL] [Abstract] [Full Text] [Related]
2. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract] [Full Text] [Related]
3. Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.
Balabanova Y; Farahmand B; Garmo H; Stattin P; Brobert G
BMJ Open; 2022 May; 12(5):e055485. PubMed ID: 35606159
[TBL] [Abstract] [Full Text] [Related]
4. The Role of Pentraxin-3, Fetuin-A and Sirtuin-7 in the diagnosis of prostate cancer.
Güzel Ö; Kösem A; Aslan Y; Asfuroglu A; Balci M; Senel C; Tuncel A
Urol J; 2021 Oct; 19(3):196-201. PubMed ID: 34655076
[TBL] [Abstract] [Full Text] [Related]
5. Out-of-pocket costs for commercially insured patients with localized prostate cancer.
Wallis CJD; Joyce DD; Klaassen Z; Luckenbaugh AN; Laviana AA; Penson D; Dusetzina SB; Barocas DA
Urol Oncol; 2021 Dec; 39(12):797-805. PubMed ID: 34600803
[TBL] [Abstract] [Full Text] [Related]
6. Radiomics Driven Diffusion Weighted Imaging Sensing Strategies for Zone-Level prostate cancer Sensing.
Dulhanty C; Wang L; Cheng M; Gunraj H; Khalvati F; Haider MA; Wong A
Sensors (Basel); 2020 Mar; 20(5):. PubMed ID: 32164378
[TBL] [Abstract] [Full Text] [Related]
7. prostate cancer diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience.
Ji J; Chen X; Xu Y; Cao Z; Xu H; Kong C; Wang F; Sun Y
Cancer Control; 2019; 26(1):1073274819887697. PubMed ID: 31793344
[TBL] [Abstract] [Full Text] [Related]
8. Management Strategies and Patient Selection After a Hospital Funding Reform for prostate cancer Surgery in Canada.
Wettstein MS; Palmer KS; Kulkarni GS; Paterson JM; Ling V; Lapointe-Shaw L; Li AH; Brown A; Taljaard M; Ivers N
JAMA Netw Open; 2019 Aug; 2(8):e1910505. PubMed ID: 31469400
[TBL] [Abstract] [Full Text] [Related]
9. The importance of histopathologic review of biopsies in patients with prostate cancer referred to a tertiary uro-oncology center.
Matheus WE; Ferreira U; Brandão EA; Ferruccio AA; Billis A
Int Braz J Urol; 2019; 45(1):32-37. PubMed ID: 30521172
[TBL] [Abstract] [Full Text] [Related]
10. Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall.
Feldman A; Borak S; Rais-Bahrami S; Gordetsky J
Int J Surg Pathol; 2018 Apr; 26(2):120-125. PubMed ID: 29166807
[TBL] [Abstract] [Full Text] [Related]
11. [Ecology and fluoroquinolon resistance profiles in febrile urinary tract infections (FUTI) after prostate needle biopsy: A retrospective study in 466 biopsies].
Duboureau H; Achkar K; Stephan R; Schmit JL; Saint F
Prog Urol; 2017 May; 27(6):345-350. PubMed ID: 28478906
[TBL] [Abstract] [Full Text] [Related]
12. Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012.
Baker BR; Basak R; Mohiuddin JJ; Chen RC
Cancer; 2016 Jul; 122(14):2234-41. PubMed ID: 27171855
[TBL] [Abstract] [Full Text] [Related]
13. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
[TBL] [Abstract] [Full Text] [Related]
14. Breast and prostate cancer survivors in a diabetic cohort: results from the Living with Diabetes Study.
Onitilo AA; Donald M; Stankowski RV; Engel JM; Williams G; Doi SA
Clin Med Res; 2013 Dec; 11(4):210-8. PubMed ID: 23669614
[TBL] [Abstract] [Full Text] [Related]
15. Androgen deprivation and thromboembolic events in men with prostate cancer.
Ehdaie B; Atoria CL; Gupta A; Feifer A; Lowrance WT; Morris MJ; Scardino PT; Eastham JA; Elkin EB
Cancer; 2012 Jul; 118(13):3397-406. PubMed ID: 22072494
[TBL] [Abstract] [Full Text] [Related]
16. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
Powe DG; Voss MJ; Zänker KS; Habashy HO; Green AR; Ellis IO; Entschladen F
Oncotarget; 2010 Nov; 1(7):628-38. PubMed ID: 21317458
[TBL] [Abstract] [Full Text] [Related]
17. Eccentric exercise versus usual-care with older cancer survivors: the impact on muscle and mobility--an exploratory pilot study.
LaStayo PC; Marcus RL; Dibble LE; Smith SB; Beck SL
BMC Geriatr; 2011 Jan; 11():5. PubMed ID: 21272338
[TBL] [Abstract] [Full Text] [Related]
18. [A proteomic study of the serum proteins in BPH and HGPIN patients].
Gu XJ; Zhu QY; Yuan L; Su J; Huang WZ; Zhang Y; Sun ZY
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):62-6. PubMed ID: 18297816
[TBL] [Abstract] [Full Text] [Related]
19. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
[TBL] [Abstract] [Full Text] [Related]
20. prostate cancer in the Baby Boomer generation: results from CaPSURE.
Scales CD; Moul JW; Curtis LH; Elkin EP; Hughes ME; Carroll PR;
Urology; 2007 Dec; 70(6):1162-7. PubMed ID: 18158039
[TBL] [Abstract] [Full Text] [Related]
[Next]
